These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 27692736)

  • 1. The effect of smoking and age on the response to first-line therapy of hidradenitis suppurativa: An institutional retrospective cohort study.
    Denny G; Anadkat MJ
    J Am Acad Dermatol; 2017 Jan; 76(1):54-59. PubMed ID: 27692736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Characteristics and Trends in Treatment Response of Hidradenitis Suppurativa Patients: A Southern US Cohort Study.
    Peterson GC; Preston A; Frieder J; Wang X; Paek SY
    Dermatology; 2020; 236(5):413-420. PubMed ID: 31935718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clindamycin versus clindamycin plus rifampicin in hidradenitis suppurativa treatment: Clinical and ultrasound observations.
    Caposiena Caro RD; Cannizzaro MV; Botti E; Di Raimondo C; Di Matteo E; Gaziano R; Bianchi L
    J Am Acad Dermatol; 2019 May; 80(5):1314-1321. PubMed ID: 30502416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Retrospective Cohort Study on Patients with Hidradenitis Suppurativa.
    Seyed Jafari SM; Knüsel E; Cazzaniga S; Hunger RE
    Dermatology; 2018; 234(1-2):71-78. PubMed ID: 29758553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of antimicrobial washes on antibacterial resistance in hidradenitis suppurativa lesions.
    Leiphart P; Ma H; Naik HB; Kirby JS
    J Am Acad Dermatol; 2019 Mar; 80(3):821-822. PubMed ID: 30403961
    [No Abstract]   [Full Text] [Related]  

  • 6. Oral clindamycin and rifampicin in the treatment of hidradenitis suppurativa-acne inversa: can some factors influence the response to the treatment?
    Bettoli V; Zauli S; Virgili A
    G Ital Dermatol Venereol; 2016 Apr; 151(2):216-8. PubMed ID: 27068603
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy of acne inversa].
    Schneider-Burrus S; Arpa E; Kors C; Stavermann T; Sabat R; Kokolakis G
    Hautarzt; 2018 Jan; 69(1):58-63. PubMed ID: 29234829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on Hidradenitis Suppurative (Part II): Treatment.
    Martorell A; García FJ; Jiménez-Gallo D; Pascual JC; Pereyra-Rodríguez J; Salgado L; Villarrasa E
    Actas Dermosifiliogr; 2015 Nov; 106(9):716-24. PubMed ID: 26277040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hidradenitis suppurativa (acne inversa): management of a recalcitrant disease.
    Lam J; Krakowski AC; Friedlander SF
    Pediatr Dermatol; 2007; 24(5):465-73. PubMed ID: 17958790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current and emerging nonsurgical treatment options for hidradenitis suppurativa.
    Kerdel FA
    Semin Cutan Med Surg; 2014 Jun; 33(3 Suppl):S57-9. PubMed ID: 25188460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patterns of antimicrobial resistance in lesions of hidradenitis suppurativa.
    Fischer AH; Haskin A; Okoye GA
    J Am Acad Dermatol; 2017 Feb; 76(2):309-313.e2. PubMed ID: 27742173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ertapenem - a potent treatment for clinical and quality of life improvement in patients with hidradenitis suppurativa.
    Braunberger TL; Nartker NT; Nicholson CL; Nahhas AF; Parks-Miller A; Hanna Z; Jayaprakash R; Ramesh MS; Rambhatla PV; Hamzavi IH
    Int J Dermatol; 2018 Sep; 57(9):1088-1093. PubMed ID: 29774531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical Treatments of Hidradenitis Suppurativa: More Options, Less Evidence.
    van der Zee HH; Gulliver WP
    Dermatol Clin; 2016 Jan; 34(1):91-6. PubMed ID: 26617362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cigarette smoking as a triggering factor of hidradenitis suppurativa.
    König A; Lehmann C; Rompel R; Happle R
    Dermatology; 1999; 198(3):261-4. PubMed ID: 10393449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hidradenitis suppurativa/acne inversa: a practical framework for treatment optimization - systematic review and recommendations from the HS ALLIANCE working group.
    Zouboulis CC; Bechara FG; Dickinson-Blok JL; Gulliver W; Horváth B; Hughes R; Kimball AB; Kirby B; Martorell A; Podda M; Prens EP; Ring HC; Tzellos T; van der Zee HH; van Straalen KR; Vossen ARJV; Jemec GBE
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):19-31. PubMed ID: 30176066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hidradenitis suppurativa: a retrospective study of 846 Dutch patients to identify factors associated with disease severity.
    Schrader AM; Deckers IE; van der Zee HH; Boer J; Prens EP
    J Am Acad Dermatol; 2014 Sep; 71(3):460-7. PubMed ID: 24880664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidradenitis suppurativa in 64 female patients: retrospective study comparing oral antibiotics and antiandrogen therapy.
    Kraft JN; Searles GE
    J Cutan Med Surg; 2007; 11(4):125-31. PubMed ID: 17601419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment experience in a local population with hidradenitis suppurativa.
    Kohorst JJ; Hagen C; Baum CL; Davis MD
    J Drugs Dermatol; 2014 Jul; 13(7):827-31. PubMed ID: 25007366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A New Perspective on Isotretinoin Treatment of Hidradenitis Suppurativa: A Retrospective Chart Review of Patient Outcomes.
    Huang CM; Kirchhof MG
    Dermatology; 2017; 233(2-3):120-125. PubMed ID: 28641306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical response rates, placebo response rates, and significantly associated covariates are dependent on choice of outcome measure in hidradenitis suppurativa: A post hoc analysis of PIONEER 1 and 2 individual patient data.
    Frew JW; Jiang CS; Singh N; Grand D; Navrazhina K; Vaughan R; Krueger JG
    J Am Acad Dermatol; 2020 May; 82(5):1150-1157. PubMed ID: 31881294
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.